is wegovy a tirzepatide or semaglutide Outperforms in Reducing Major Adverse Cardiovascular Events Ozempic vs. Zepbound: How semaglutide

Lancet 338, 985992

Inconsistent timing patterns can also reduce effectiveness

The FDA previously granted Breakthrough Therapy designation to Dupixent for the treatment of severe atopic dermatitis in children 6 months to 11 years of age not well controlled on topical prescription medications

They can serve an important role when a licensed prescriber determines that an FDA-approved product does not meet an individual patients clinical needs, but they should not be marketed or understood as equivalent to FDA-approved products

Recent advances in diabetic kidney diseases: from kidney injury to kidney fibrosis

BMJ 2011;343:d5931